Valhi, Inc. filings document an NYSE-listed operating company with common stock trading under VHI and businesses in chemicals, component products, and real estate management and development. Form 8-K reports furnish quarterly and annual operating results, dividend announcements, material agreements and debt-related obligations involving affiliated chemicals operations, and officer or accounting-role changes.
Proxy materials cover annual meeting notices, director and stockholder voting matters, voting procedures, and governance information. The filing record also includes exhibits such as earnings releases, dividend releases, indenture-related agreements, and Inline XBRL cover-page data tied to Valhi's public-company reporting.
Valhi, Inc. reported a swing to a quarterly loss as markets softened and costs rose. For the quarter ended September 30, 2025, total revenues and other income were $524.1 million (down from $558.8 million), and the company posted a net loss of $21.9 million versus net income of $85.6 million a year ago. Net sales were $503.5 million, with Chemicals lower and Component Products higher.
Year-to-date, revenues were $1.635 billion and net income was $8.4 million. Operating cash flow was $(136.1) million, driven by working capital outflows and $56.5 million of environmental payments. Cash and restricted cash ended at $223.9 million, and total debt increased to $662.3 million, largely from Kronos’ additional €75 million 9.50% notes due 2029 and Global Revolver usage.
Segment trends were mixed: Chemicals recorded an operating loss in the quarter, while Component Products improved and Real Estate delivered solid income supported by $34.5 million in infrastructure reimbursement year-to-date. The environmental accrual decreased to $18.1 million after payments. The quarterly dividend remained $0.08 per share, and shares outstanding were 28,302,293 as of November 3, 2025.
Valhi, Inc. reported a swing to a quarterly loss as markets softened and costs rose. For the quarter ended September 30, 2025, total revenues and other income were $524.1 million (down from $558.8 million), and the company posted a net loss of $21.9 million versus net income of $85.6 million a year ago. Net sales were $503.5 million, with Chemicals lower and Component Products higher.
Year-to-date, revenues were $1.635 billion and net income was $8.4 million. Operating cash flow was $(136.1) million, driven by working capital outflows and $56.5 million of environmental payments. Cash and restricted cash ended at $223.9 million, and total debt increased to $662.3 million, largely from Kronos’ additional €75 million 9.50% notes due 2029 and Global Revolver usage.
Segment trends were mixed: Chemicals recorded an operating loss in the quarter, while Component Products improved and Real Estate delivered solid income supported by $34.5 million in infrastructure reimbursement year-to-date. The environmental accrual decreased to $18.1 million after payments. The quarterly dividend remained $0.08 per share, and shares outstanding were 28,302,293 as of November 3, 2025.
Valhi, Inc. filed a Form 8-K to report information by reference to a separate filing made by its affiliate, Kronos Worldwide, Inc. The company states that the information disclosed by Kronos Worldwide under Items 1.01 and 2.03 of its Form 8-K dated September 15, 2025 is incorporated into Valhi’s report.
Exhibits listed include a Third Supplemental Indenture dated September 15, 2025 among Kronos International, Inc., certain guarantors, and Deutsche Bank Trust Company Americas, and an Additional Notes Priority Joinder Agreement dated the same day with Deutsche Bank Trust Company Americas as trustee and collateral agent. These documents, which relate to Kronos Worldwide’s debt arrangements, are incorporated by reference rather than reproduced in full.